MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A randomised control trial to investigate if people with Parkinson’s disease can exercise at high intensity, and does this improve their cardiorespiratory function? A feasibility study

M. Harvey, R. Walker, W. Gray, K. Weston, L. Oates (North Shields, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 1178

Keywords: Rehabilitation

Session Information

Date: Thursday, June 8, 2017

Session Title: Clinical Trials and Therapy in Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To assess whether people with Parkinson’s disease (PD) are able to exercise at ≥85% of maximal heart rate during High Intensity Interval Training (HIIT) and does this improve their cardiorespiratory function. 

Background: Physical exercise is recommended for people with PD in UK and European guidelines. However, there is little consensus on the most appropriate exercise regimes. Few previous studies of exercise in PD have looked at the effect of exercise interventions on peak or maximal oxygen consumption. Therefore, there is limited evidence to inform exercise programme design.  .  The primary outcome measures were a heart rate of ≥85% of predicted maximum and cardiorespiratory fitness (VO2max). 

Methods: A stepped wedged study design was used to assess the feasibility of HIIT within PD.  A total of 20 participants with Idiopathic Parkinson’s Disease (IPD) (Hoehn and Yahr stage 1-3) were randomly assigned to intervention group I or II. Both groups completed a VO2 max test at baseline which took place at North Tyneside General Hospital. The intervention start was then delayed for group II until group I had completed their intervention and both groups had been re-assessed. The Intervention took place at the Speedflex clinic, Newcastle-upon-Tyne, UK and involved participants performing three HIIT sessions per week for 12 weeks.  Each session consisted of four-minute periods of HIIT designed to elicit ≥85% max heart rate and this was repeated four– six times per session.

Results: Both groups achieved a heart rate of ≥85% of predicted maximum, with a significant increase across the intervention period (average 0.23% per week p=0.019).  Change in VO2max was significant p = .041. 

Conclusions: Patients with PD can exercise at ≥85% of maximal predicted heart rate.  A 12-week HIIT programme, with a gradual increase in exercise intensity gave a significant improvement on mean peak heart rate and cardiorespiratory fitness.  

To cite this abstract in AMA style:

M. Harvey, R. Walker, W. Gray, K. Weston, L. Oates. A randomised control trial to investigate if people with Parkinson’s disease can exercise at high intensity, and does this improve their cardiorespiratory function? A feasibility study [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/a-randomised-control-trial-to-investigate-if-people-with-parkinsons-disease-can-exercise-at-high-intensity-and-does-this-improve-their-cardiorespiratory-function-a-feasibility-study/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-randomised-control-trial-to-investigate-if-people-with-parkinsons-disease-can-exercise-at-high-intensity-and-does-this-improve-their-cardiorespiratory-function-a-feasibility-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley